Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: Catholic Research Network for Multiple Myeloma Study (CARE-MM 2203)
Research Square (Research Square)